Nicholas P. Restifo - Concepedia

Author

Nicholas P. Restifo

Also Known As

F Cichocki, Graham Anderson, N P Restifo, N Restifo, N. P. Restifo, N. Restifo, Nicholas P. Restifo, Nicholas P Restifo, Nicholas P. Restifo, Nicholas Restifo

674

Publications

95.6K

Citations

149

H-Index

160

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institute of Allergy and Infectious Diseases Howard Hughes Medical Institute

About

Nicholas P. Restifo is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	89	147	35.3K
2	Health Sciences	6	6	1.2K
3	Natural Sciences	4	4	281
4	Education	1	1	221
5	Social Sciences	1	1	1.9K

Nicholas P. Restifo

281

Publications

74.8K

Citations

132

H-Index

Page 1

	Year	Citations
Cancer immunotherapy: moving beyond current vaccines Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo Nature Medicine VaccinationTumor ImmunologyCancer ImmunosurveillanceImmunologyTumor Immunity	2004	3K
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, Science	2002	2.8K
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Science Lymphoid NeoplasiaCell TherapyCancer ImmunosurveillanceMedicineCancer Regression	2006	2.6K
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Clinical Cancer Research	2011	2.1K
A human memory T cell subset with stem cell–like properties Luca Gattinoni, Enrico Lugli, Yun Ji, Nature Medicine Human CellMedicineMemoryStem Cell ResearchNeuroscience	2011	1.9K
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Nature Medicine VaccinationTherapeutic EvaluationMelanomaImmunologyMetastatic Melanoma	1998	1.8K
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Journal of Clinical Oncology	2005	1.6K
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, Journal of Clinical Oncology	2011	1.6K
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Proceedings of the National Academy of Sciences	2003	1.6K
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Blood	2009	1.4K

Page 1